Mercer Global Advisors
IGC icon

Mercer Global Advisors’s IGC Pharma IGC Stock Holding History

Mercer Global Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300 Buy
+1,104
New +$326 ﹤0.01% 5887

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 4.87% 1-Year Est. Return

Mercer Global Advisors's IGC Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in IGC Pharma (IGC) in Q2 2026: 1,104 shares worth $300. The stake represents ﹤0.01% of the portfolio and ranks #5887 among its holdings.

29 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Mercer Global Advisors held 1,104 shares of IGC Pharma worth $300 as of Q2 2026.
  • IGC Pharma was a new Mercer Global Advisors position in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5887 holding.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.